Considerations in the Evaluation of Real-World Evidence for Patients with Multiple Myeloma: Efficacy and Safety Considerations to Inform Therapy

Considerations in the Evaluation of Real-World Evidence for Patients with Multiple Myeloma: Efficacy and Safety Considerations to Inform Therapy is organized by Med Learning Group.,Release Date: May 20, 2022,Expiration Date: May 20, 2023,Program Overview:,This enduring TeleECHO program will explore the role of real-world evidence in informing management decisions of elderly and frail patients with relapsed and refractory multiple myeloma (RRMM). A brief didactic presentation will discuss prognostic features and key management considerations for the elderly and frail patient populations. A summary of clinical trial data and real-world evidence to inform treatment selection in the first-line and relapse settings will also be presented. Interactive case studies will illustrate strategies for patient counseling and treatment selection in elderly and frail patients with RRMM.,Learning Objectives:,Upon the completion of this program, attendees should be able to:,• Evaluate considerations in the management of multiple myeloma in elderly and frail populations, including features of the prognosis and prognostic evaluation of these patients,• Summarize clinical trial outcomes and the role of real-world evidence in informing treatment decisions in patients who are less likely to be considered for clinical trial enrollment,• Analyze clinical trial outcomes and real-world evidence to inform patient counseling and treatment decisions in frail and elderly patients with multiple myeloma